120
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Serum YKL-40 Levels Predict Endotypes and Associate with Postoperative Recurrence in Patients with Chronic Rhinosinusitis with Nasal Polyps

, , , , & ORCID Icon
Pages 1295-1306 | Published online: 29 Oct 2021

References

  • Abbas EE, Li C, Xie A, et al. Distinct clinical pathology and microbiota in chronic rhinosinusitis with nasal polyps endotypes. Laryngoscope. 2021;131(1):E34–e44. doi:10.1002/lary.28858
  • Avdeeva K, Fokkens W. Precision medicine in chronic rhinosinusitis with nasal polyps. Curr Allergy Asthma Rep. 2018;18(4):25. doi:10.1007/s11882-018-0776-8
  • Han JK. Subclassification of chronic rhinosinusitis. Laryngoscope. 2013;123(Suppl 2):S15–S27. doi:10.1002/lary.23979
  • Staudacher AG, Peters AT, Kato A, Stevens WW. Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2020;124(4):318–325. doi:10.1016/j.anai.2020.01.013
  • Ikeda K, Shiozawa A, Ono N, et al. Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil. Laryngoscope. 2013;123(11):E1–E9. doi:10.1002/lary.24154
  • Hu Y, Cao PP, Liang GT, Cui YH, Liu Z. Diagnostic significance of blood eosinophil count in eosinophilic chronic rhinosinusitis with nasal polyps in Chinese adults. Laryngoscope. 2012;122(3):498–503. doi:10.1002/lary.22507
  • Zhong B, Yuan T, Du J, et al. The role of preoperative blood eosinophil counts in distinguishing chronic rhinosinusitis with nasal polyps phenotypes. Int Forum Allergy Rhinol. 2021;11(1):16–23. doi:10.1002/alr.22636
  • Pouyafar A, Heydarabad MZ, Mahboob S, Mokhtarzadeh A, Rahbarghazi R. Angiogenic potential of YKL-40 in the dynamics of tumor niche. Biomed Pharmacother. 2018;100:478–485. doi:10.1016/j.biopha.2018.02.050
  • Abd El-Fattah AA, Sadik NAH, Shaker OG, Mohamed Kamal A. Single nucleotide polymorphism in SMAD7 and CHI3L1 and colorectal cancer risk. Mediators Inflamm. 2018;2018:9853192. doi:10.1155/2018/9853192
  • Lai T, Wu D, Chen M, et al. YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling. Respir Res. 2016;17(1):31. doi:10.1186/s12931-016-0338-3
  • Zhou Y, Peng H, Sun H, et al. Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis. Sci Transl Med. 2014;6(240):240ra276. doi:10.1126/scitranslmed.3007096
  • Park SJ, Jun YJ, Kim TH, et al. Increased expression of YKL-40 in mild and moderate/severe persistent allergic rhinitis and its possible contribution to remodeling of nasal mucosa. Am J Rhinol Allergy. 2013;27(5):372–380. doi:10.2500/ajra.2013.27.3941
  • Schoneveld L, Ladang A, Henket M, Frix AN, Cavalier E, Guiot J. YKL-40 as a new promising prognostic marker of severity in COVID infection. Crit Care. 2021;25(1):66. doi:10.1186/s13054-020-03383-7
  • Ma Y, Wu S, Cai X, Li X, Feng X. [Expression of YKL-40 and TLR4 in patients with chronic rhinosinusitis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015;50(4):300–305. Chinese.
  • Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1–12. doi:10.4193/Rhino50E2
  • Qi S, Yan B, Liu C, Wang C, Zhang L. Predictive significance of Charcot-Leyden crystal mRNA levels in nasal brushing for nasal polyp recurrence. Rhinology. 2020;58(2):166–174.
  • Zhu Z, Wang W, Zhang X, et al. Nasal fluid cytology and cytokine profiles of eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps. Rhinology. 2020;58(4):314–322.
  • Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993;31(4):183–184.
  • Wen W, Liu W, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol. 2012;129(6):1522–1528.e1525. doi:10.1016/j.jaci.2012.01.079
  • Long X, He X, Ohshimo S, et al. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis. Eur Respir J. 2017;49(2):1501924. doi:10.1183/13993003.01924-2015
  • Deng Y, Li G, Chang D, Su X. YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases. Clin Chim Acta. 2020;511:40–46. doi:10.1016/j.cca.2020.09.035
  • Kong Y, Zhang S, Su X, Peng D, Su Y. Serum levels of YKL-40 are increased in patients with psoriasis: a meta-analysis. Postgrad Med. 2019;131(6):405–412. doi:10.1080/00325481.2019.1643634
  • Wang J, Lv H, Luo Z, et al. Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD. Respir Res. 2018;19(1):47. doi:10.1186/s12931-018-0755-6
  • Konradsen JR, James A, Nordlund B, et al. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma. J Allergy Clin Immunol. 2013;132(2):328–335.e325. doi:10.1016/j.jaci.2013.03.003
  • Lee CG, Da Silva CA, Dela Cruz CS, et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73(1):479–501. doi:10.1146/annurev-physiol-012110-142250
  • Lee CG, Hartl D, Lee GR, et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med. 2009;206(5):1149–1166. doi:10.1084/jem.20081271
  • Watson B, Gauvreau GM. Thymic stromal lymphopoietin: a central regulator of allergic asthma. Expert Opin Ther Targets. 2014;18(7):771–785. doi:10.1517/14728222.2014.915314
  • Wang L, Bao A, Zheng Y, et al. Adenovirus vector-mediated YKL-40 shRNA attenuates eosinophil airway inflammation in a murine asthmatic model. Gene Ther. 2021;28(3–4):177–185. doi:10.1038/s41434-020-00202-0
  • Kang MJ, Yoon CM, Nam M, et al. Role of chitinase 3-like-1 in interleukin-18-induced pulmonary type 1, type 2, and type 17 inflammation; alveolar destruction; and airway fibrosis in the Murine lung. Am J Respir Cell Mol Biol. 2015;53(6):863–871. doi:10.1165/rcmb.2014-0366OC
  • Ma Y, Zheng C, Shi L. The role of YKL40 in the pathogenesis of CRS with nasal polyps. Eur Arch Otorhinolaryngol. 2018;275(2):431–438. doi:10.1007/s00405-017-4859-2
  • Peng J, Yu Q, Fan S, et al. High blood eosinophil and YKL-40 levels, as well as low CXCL9 levels, are associated with increased readmission in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2021;16:795–806. doi:10.2147/COPD.S294968
  • Ouyang Y, Fan E, Li Y, Wang X, Zhang L. Clinical characteristics and expression of thymic stromal lymphopoietin in eosinophilic and non-eosinophilic chronic rhinosinusitis. ORL J Otorhinolaryngol Relat Spec. 2013;75(1):37–45. doi:10.1159/000346929
  • Shah SA, Ishinaga H, Takeuchi K. Pathogenesis of eosinophilic chronic rhinosinusitis. J Inflamm. 2016;13(1):11. doi:10.1186/s12950-016-0121-8
  • Xu M, Chen D, Zhou H, Zhang W, Xu J, Chen L. The role of periostin in the occurrence and progression of eosinophilic chronic sinusitis with nasal polyps. Sci Rep. 2017;7(1):9479. doi:10.1038/s41598-017-08375-2
  • Allakhverdi Z, Delespesse G. Hematopoietic progenitor cells are innate Th2 cytokine-producing cells. Allergy. 2012;67(1):4–9. doi:10.1111/j.1398-9995.2011.02703.x
  • Ben SQ, Qiu YL, Zhou J, et al. Ovalbumin enhances YKL-40, IL-5, GM-CSF, and eotaxin expression simultaneously in primarily cultured mouse tracheal epithelial cells. In Vitro Cell Dev Biol Anim. 2014;50(3):243–250. doi:10.1007/s11626-013-9698-x
  • Zhang L, Zhang Y, Gao Y, et al. Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma. Rhinology. 2020;58(2):126–135.
  • Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol. 2011;120(3):162-166
  • Morrissey DK, Bassiouni A, Psaltis AJ, Naidoo Y, Wormald PJ. Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis. Int Forum Allergy Rhinol. 2016;6(8):820–825. doi:10.1002/alr.21739
  • Tosun F, Arslan HH, Karslioglu Y, Deveci MS, Durmaz A. Relationship between postoperative recurrence rate and eosinophil density of nasal polyps. Ann Otol Rhinol Laryngol. 2010;119(7):455–459. doi:10.1177/000348941011900705
  • Vlaminck S, Vauterin T, Hellings PW, et al. The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: a 3-year prospective observational study. Am J Rhinol Allergy. 2014;28(3):260–264. doi:10.2500/ajra.2014.28.4024
  • Van Zele T, Holtappels G, Gevaert P, Bachert C. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2014;28(3):192–198. doi:10.2500/ajra.2014.28.4033
  • Brescia G, Contro G, Giacomelli L, Barion U, Frigo AC, Marioni G. Blood eosinophilic and basophilic trends in recurring and non-recurring eosinophilic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2021;35(3):296–301. doi:10.1177/1945892420953960